Extended trial tests obesity drug's long-term safety for rare genetic conditions
NCT ID NCT06596135
Summary
This study continues testing setmelanotide, a medication for rare genetic forms of obesity, to check its long-term safety. It's for patients aged 2 and older who have already taken the drug in a previous trial and showed benefit. The main goal is to monitor side effects and how well people tolerate continued treatment over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY ASSOCIATED WITH DEFECTS IN LEPTIN-MELANOCORTIN PATHWAY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's Minnesota
Saint Paul, Minnesota, 55102, United States
-
Geisinger Health System
Danville, Pennsylvania, 17821, United States
-
HonorHealth Research Institute
Scottsdale, Arizona, 85258, United States
-
M3 Wake Research, Inc
Raleigh, North Carolina, 27612, United States
-
Marshfield Clinical Research Institute
Marshfield, Wisconsin, 54449, United States
-
Mayo Clinic - Rochester
Rochester, Minnesota, 55905, United States
-
Seattle Children's Research Institute
Seattle, Washington, 98105, United States
-
UC San Diego- Rady Children's Hospital
San Diego, California, 92123, United States
-
University of Buffalo
Getzville, New York, 14068, United States
-
University of Florida at Gainesville
Gainesville, Florida, 32611, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
Vanderbilt University School of Medicine
Nashville, Tennessee, 37232, United States
-
WR-ClinSearch
Chattanooga, Tennessee, 37421, United States
Conditions
Explore the condition pages connected to this study.